secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2023-08-18T23:59:59+00:00
Accession:  0001104659-23-093483
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

First Wave BioPharma receives Nasdaq deficiency notice for stockholders' equity below $2.5M
--------------------------------------------------------------------------------

- Stockholders' equity of $881,960 as of June 30, 2023, below Nasdaq's $2.5M minimum.
- Company has until Oct 2, 2023 to submit a plan to regain compliance.
- If Nasdaq accepts plan, extension possible until Feb 13, 2024.
- Company intends to submit a compliance plan but no assurance of acceptance.
- Also failed alternative standards: market value $35M or net income $500K requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465923093483/0001104659-23-093483-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465923093483/tm2324085-1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-093483

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer